Q3 2026 · 1 tracked holders Data updated 17 Nov 2026 · SEC filings

DAMORA THERAPEUTICS INC

DAMORA THERAPEUTICS INC

Ownership in Q3 2026 · CUSIP G2646Y104

Investors holding this security
1
In available Q3 2026 reports
Combined reported value
$25.71M
Across tracked holders
New holders this quarter
1
Compared with the prior reported quarter

An ownership snapshot from SEC filings. Portfolio % measures each investor's exposure, not their share of the company.

Investors & position changes

Investor Portfolio % Change Shares change Reported value Shares Price after filing Return since filing
Viking Global Investors Disclosed 16 Nov 2026 0.08% New New $25.71M 1.21M — —

Reported holdings can change before they become public. The optional return figures measure price change after disclosure, not an investor's actual profit. Price coverage and filing dates differ.

Number of holders
Combined reported value